Ding H, Tao B, Xu L, Jiang G, et al. Neoadjuvant Immunochemotherapy for Stage II-IIIB Non-Small Cell Lung Cancer with Mutations Beyond EGFR 19del, L858R, and ALK rearrangement. Ann Thorac Surg 2025 May 6:S0003-4975(25)00378.
PMID: 40339974